Lack of Association Between LIG4 Gene Polymorphisms and the Risk of Breast Cancer: A HuGE Review and Meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3417-3422

  Zhou, Li Ping ^a   Luan, Hong ^a   Dong, Xi Hua ^a   Jin, Guo Jiang ^a   Man, Dong Liang ^a   Shang, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; LIG4; Meta analysis; Mutation rate; Polymorphism

Indexed keywords

EID: 84873589081     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3417     Document Type: Article

References (44)

1. Acevedo N, Mercado D, Vergara C, et al (2009). Association between total immunoglobulin E and antibody responses to naturally acquired Ascaris lumbricoides infection and polymorphisms of immune system-related LIG4, TNFSF13B and IRS2 genes. Clin Exp Immunol, 157, 282-90.
2. Balmain A, Gray J, Ponder B (2003). The genetics and genomics of cancer. Nat Genet, 33 (Suppl), 238-44.
3. (2006) Breast Cancer Association Consortium Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst, 98, 1382-96.
4. Cao AY, Huang J, Hu Z, et al (2009). Mutation analysis of BRIP1/ BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat, 115, 51-5.
5. Dapic V, Carvalho MA, Monteiro AN (2005). Breast cancer susceptibility and the DNA damage response. Cancer Control, 12, 127-136.
6. Ferguson DO, Alt FW. (2001) DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene, 20, 5572-9.
7. Frank-Vaillant M, Marcand S (2001). NHEJ regulation by mating type is exercised through a novel protein, Lif2p, essential to the ligase IV pathway. Genes Dev, 15, 3005-12.
8. Fu YP, Yu JC, Cheng TC, et al (2003). Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res, 63, 2440-6.
9. Garcia AM, Salomon RN, Witsell A, et al (2011). Loss of the bloom syndrome helicase increases DNA ligase 4-independent genome rearrangements and tumorigenesis in aging Drosophila. Genome Biol, 12, R121.
10. García-Closas M, Egan KM, Newcomb PA, et al (2006). Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet, 119, 376-88.
11. Goode EL, Dunning AM, Kuschel B, et al (2002). Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res, 62, 3052-7.
12. Grabarz A, Barascu A, Guirouilh-Barbat J, et al (2012). Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end joining. Am J Cancer Res, 2, 249-68.
13. Han J, Hankinson SE, Ranu H, et al (2004). Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study. Carcinogenesis, 25, 189-95.
14. Henrique Barreta M, Garziera Gasperin B, Braga Rissi V, et al (2012). Homologous recombination and non-homologous end-joining repair pathways in bovine embryos with different developmental competence. Exp Cell Res, (in press).
15. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
16. Hsu HM, Wang HC, Chen ST, et al (2007) Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol Biomarkers Prev, 16, 2024-32.
17. Jakubowska A, Gronwald J, Menkiszak J, et al (2010). BRCA1- associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat, 119, 201-11.
18. Kapusta A, Matsuda A, Marmignon A, et al (2011) Highly precise and developmentally programmed genome assembly in Paramecium requires ligase IV-dependent end joining. PLoS Genet, 7, e1002049.
19. Kuschel B, Auranen A, McBride S, et al (2002). Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet, 11, 1399-407.
20. Lacey JV Jr, Devesa SS, Brinton LA (2002). Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen, 39, 82-8.
21. Li Z, Luo Y, Gong Y, et al (2011). Clinical features and molecular phenotypes of breast cancer in patients with type-2 diabetes mellitus. Asian Pac J Cancer Prev, 12, 2183-8.
22. Liang L, Deng L, Nguyen SC, et al (2008). Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks. Nucleic Acids Res, 36, 3297-310.
23. Mahaney BL, Meek K, Lees-Miller SP (2009). Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J, 417, 639-50.
24. Mao Z, Bozzella M, Seluanov A, et al (2008). DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle, 7, 2902-6.
25. Matullo G, Dunning AM, Guarrera S, et al (2006) DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis, 27, 997-1007.
26. Monsees GM, Kraft P, Chanock SJ, et al (2011) Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk. Breast Cancer Res Treat, 125, 207-14.
27. Okoh V, Deoraj A, Roy D (2011). Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer. Biochim Biophys Acta, 1815, 115-33.
28. Parkin DM, Bray F, Ferlay J, et al (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6.
29. Pastwa E, Błasiak J (2003). Non-homologous DNA end joining. Acta Biochim Pol, 50, 891-908.
30. Peters JL, Sutton AJ, Jones DR,et al (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295, 676-80.
31. Peto J, Collins N, Barfoot R, et al (1999). Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst, 91, 943-9.
32. Ponder BA (2001). Cancer genetics. Nature, 411, 336-41.
33. Rafii S, O'Regan P, Xinarianos G, et al (2002). A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. Hum Mol Genet, 11, 1433-8.
34. Rothkamm K, Krüger I, Thompson LH, et al (2003) Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol, 23, 5706-15.
35. Shrivastav M, De Haro LP, Nickoloff JA (2008). Regulation of DNA double-strand break repair pathway choice. Cell Res, 18, 134-47.
36. Symington LS, Gautier J (2011). Double-strand break end resection and repair pathway choice. Annu Rev Genet, 45, 247-71.
37. Venkitaraman AR (2002). Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell, 108, 171-82.
38. von Elm E, Altman DG, Egger M, et al (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet, 370, 1453-7.
39. Wang HX, Ying MZ, Wang YJ (2012). Association of DNA double strand break repair pathway and hereditary breast cancer. Chin Clin Oncol, 17, 267-71.
40. Wernberg JA, Yap J, Murekeyisoni C, et al (2009). Multiple primary tumors in men with breast cancer diagnoses: a SEER database review. J Surg Oncol, 99, 16-9.
41. Yano K, Morotomi-Yano K, Adachi N,et al (2009). Molecular mechanism of protein assembly on DNA double-strand breaks in the non-homologous end-joining pathway. J Radiat Res, 50, 97-108.
42. Yoshida K, Miki Y (2004). Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci, 95, 866-71.
43. Zhang L, Liu JL, Zhang YJ, et al (2011). Association between HLA-B* 27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin Exp Rheumatol, 29, 285-92.
44. Zintzaras E, Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol, 28, 123-37.